Here's What Analysts Are Forecasting For Revenio Group Oyj (HEL:REG1V) After Its Annual Results
Feb 16
Have your own idea? Try our Stock Screener
Finnish (OMX) Healthcare Sector Analysis
UpdatedFeb 16, 2025
DataAggregated Company Financials
Companies15
- 7D-2.5%
- 3M12.6%
- 1Y25.5%
- YTD12.2%
Over the last 7 days, the Healthcare industry has dropped 2.5%, driven by declines in Terveystalo Oyj and Orion Oyj of 8.3% and 1.6%, respectively. In contrast, Pihlajalinna Oyj has gained 11%. In the past year, the industry has gained 26%. Looking forward, earnings are forecast to grow by 15% annually.
Sector Valuation and Performance
Has the Finnish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 16 Feb 2025 | €10.5b | €5.3b | €372.7m | 19.2x | 28.1x | 2x |
| Tue, 14 Jan 2025 | €9.4b | €5.2b | €274.3m | 27.3x | 34.3x | 1.8x |
| Thu, 12 Dec 2024 | €9.2b | €5.2b | €274.3m | 19.9x | 33.6x | 1.8x |
| Sat, 09 Nov 2024 | €9.4b | €5.2b | €275.9m | 20.7x | 34.1x | 1.8x |
| Mon, 07 Oct 2024 | €10.0b | €5.0b | €144.2m | 24.9x | 69.1x | 2x |
| Wed, 04 Sep 2024 | €10.2b | €5.0b | €143.6m | 25.3x | 70.9x | 2x |
| Fri, 02 Aug 2024 | €9.2b | €5.0b | €123.3m | 29.9x | 74.7x | 1.9x |
| Sun, 30 Jun 2024 | €8.5b | €4.9b | €115.7m | 28.3x | 73.7x | 1.7x |
| Tue, 28 May 2024 | €8.3b | €4.9b | €118.1m | 28.2x | 70.1x | 1.7x |
| Thu, 25 Apr 2024 | €7.4b | €4.8b | €108.0m | 30.2x | 68.5x | 1.5x |
| Sat, 23 Mar 2024 | €7.4b | €4.8b | €108.1m | 29.3x | 68.6x | 1.5x |
| Mon, 19 Feb 2024 | €8.3b | €4.8b | €110.2m | 27.6x | 75.3x | 1.7x |
| Wed, 17 Jan 2024 | €8.8b | €4.8b | €135.4m | 33x | 65.3x | 1.8x |
| Fri, 15 Dec 2023 | €7.9b | €4.8b | €135.4m | 31x | 58x | 1.6x |
| Sun, 12 Nov 2023 | €7.5b | €4.8b | €134.3m | 29.7x | 55.5x | 1.6x |
| Tue, 10 Oct 2023 | €7.8b | €5.0b | €270.4m | 27.2x | 28.8x | 1.6x |
| Thu, 07 Sep 2023 | €7.8b | €5.0b | €269.6m | 26.7x | 28.9x | 1.6x |
| Sat, 05 Aug 2023 | €7.3b | €5.0b | €277.7m | 24.6x | 26.3x | 1.5x |
| Mon, 03 Jul 2023 | €8.3b | €5.0b | €315.2m | 39.7x | 26.2x | 1.7x |
| Wed, 31 May 2023 | €8.6b | €5.0b | €315.2m | 39x | 27.1x | 1.7x |
| Fri, 28 Apr 2023 | €9.2b | €5.0b | €343.2m | 40.7x | 26.8x | 1.9x |
| Sun, 26 Mar 2023 | €8.7b | €5.0b | €335.5m | 34.9x | 25.8x | 1.7x |
| Tue, 21 Feb 2023 | €9.6b | €5.0b | €335.6m | 39.7x | 28.6x | 1.9x |
| Thu, 19 Jan 2023 | €10.1b | €5.3b | €373.8m | 19.9x | 26.9x | 1.9x |
| Sat, 17 Dec 2022 | €10.2b | €5.3b | €373.8m | 18.3x | 27.3x | 1.9x |
| Mon, 14 Nov 2022 | €9.7b | €5.3b | €384.8m | 18.7x | 25.1x | 1.8x |
| Wed, 12 Oct 2022 | €9.2b | €5.0b | €282.1m | 17.6x | 32.5x | 1.8x |
| Fri, 09 Sep 2022 | €9.8b | €5.0b | €284.2m | 18.8x | 34.6x | 2x |
| Sun, 07 Aug 2022 | €10.5b | €5.0b | €288.2m | 20.2x | 36.5x | 2.1x |
| Tue, 05 Jul 2022 | €9.9b | €4.9b | €277.1m | 26.2x | 35.6x | 2x |
| Thu, 02 Jun 2022 | €9.4b | €4.9b | €277.1m | 27.3x | 34x | 1.9x |
| Sat, 30 Apr 2022 | €9.5b | €4.9b | €277.1m | 27.5x | 34.2x | 1.9x |
| Mon, 28 Mar 2022 | €9.8b | €4.8b | €280.7m | 29.1x | 34.8x | 2x |
| Wed, 23 Feb 2022 | €10.3b | €4.8b | €281.5m | 31.2x | 36.7x | 2.2x |
Price to Earnings Ratio
36.7x
Current Industry PE
- Investors are pessimistic on the Finnish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 36.2x which is lower than its 3-year average PE of 43.0x.
- The 3-year average PS ratio of 1.8x is lower than the industry's current PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 3.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare sector?
| FI Market | 2.29% | |
| Healthcare | -2.50% | |
| Biotech | 5.91% | |
| Healthtech | 1.69% | |
| Life Sciences | 0.85% | |
| Pharma | -1.60% | |
| Healthcare Services | -4.27% | |
| Medical Equipment | -5.85% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 240x.
- Analysts are expecting annual earnings growth of 27.9%, which is higher than its past year's earnings growth of 18.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 28% over the next 5 years.
- In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PIHLIS Pihlajalinna Oyj | €11.90 | 10.7% +€25.9m | 60.8% | PE9.8x | |
| HEALTH Nightingale Health Oyj | €2.91 | 4.7% +€7.8m | 168.0% | PS40.3x | |
| AIFORIA Aiforia Technologies Oyj | €3.60 | 1.7% +€1.7m | -1.6% | PS37.1x | |
| OKDBV Oriola Oyj | €0.97 | 0.6% +€1.1m | -7.4% | PS0.1x | |
| NANOFH Nanoform Finland Oyj | €1.19 | 0.8% +€855.3k | -60.5% | PS41.9x |
